We are live on ! Find out more
ABEOW

Abeona Therapeutics Inc Warrant
ABEOW

Delisted

ABEOW was delisted on the 20th of December, 2019.

Back to rankings

4 hedge funds and large institutions have $2.74M invested in Abeona Therapeutics Inc Warrant in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $2.06M → $2.74M (+$684K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$170

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$1.91M – – –
HCM
2
Highbridge Capital Management
New York
$835K – – –
UBS Group
3
UBS Group
Switzerland
– -$2K -538 Closed
WAM
4
Wolverine Asset Management
Illinois
– +$170 +55 New

ABEOW Hedge Fund Activity: Q1 2019 in Review

4 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q1 2019, worth a combined $2.74M — up 33% from $2.06M a quarter earlier.

Fund positioning in ABEOW was balanced in Q1 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $170. The largest seller was UBS Group, exiting entirely with an estimated $2K sold.

  • 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $2.74M of Abeona Therapeutics Inc Warrant stock for Q1 2019, up 33% quarter-over-quarter.
  • 1 fund opened new Abeona Therapeutics Inc Warrant positions in Q1 2019 and 1 closed out, a net change of 0 holders.
  • The largest Abeona Therapeutics Inc Warrant buyer in Q1 2019 was Wolverine Asset Management, an estimated $170 added.
  • The largest Abeona Therapeutics Inc Warrant seller in Q1 2019 was UBS Group, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2019.